DealsVivera Pharmaceuticals scores $440m from JR Dallas Wealth ManagementVivera Pharmaceuticals, a pharmaceutical company, has raised $440 million in funding.ByIris Dorbian30 November 2020•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs